Chemotherapy during pregnancy: When and how?;CHIMIOTHERAPIES PENDANT LA GROSSESSE: QUAND ET COMMENT? LA PARTICULARITE DES CANCERS GYNECOLOGIQUES ET MAMMAIRES.

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 26, Issue SUPPL. 3, 1997, Pages 197-200

  Giacalone, P L ^a   Benos P ^a   Charlier, C ^a   Laffargue, F ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTOTOXIC AGENT; DAUNORUBICIN; METHOTREXATE;

BREAST CANCER; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONGENITAL MALFORMATION; DRUG CYTOTOXICITY; FEMALE; FETUS; FRANCE; GYNECOLOGIC CANCER; HUMAN; RISK FACTOR; TERATOGENICITY; BREAST TUMOR; DRUG CONTRAINDICATION; DRUG EFFECT; FEMALE GENITAL TRACT TUMOR; FETOMATERNAL TRANSFUSION; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; FETUS; GENITAL NEOPLASMS, FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 0030699357     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Doll DC. Chemotherapy in pregnancy. In: Perry MC, ed. The chemotherapy source book. Baltimore: Williams and Wilkins, 1992: 703-709.
2. Schapira D, Chudley A. Successfull pregnancy following continuous treatment with combination chemotherapy before conception and throughout pregnancy. Cancer 1984;54:800-803.
3. Randall T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA 1993;269:323.
4. Doll DC, Ringenberg S, Yabro J. Antineoplastic agents and pregnancy. Semin Oncol 1989;16:337-346.
5. Boehnke LL. Chemotherapy during pregnancy : teratogenesis and other acute effects. Cancer Bull 1994;46:385-390.
6. Metz SA, Day TG, Pursell H. Adjuvant chemotherapy in a pregnant patient with endodermal sinus tumor of the ovary. Gynecol Oncol 1989;32:371-374.
7. Gililland J, Weinstein L. The effects of cancer chemotherapeutic agents on the developping fetus. Obstet Gynecol Surv 1983;38:6-13.
8. Nicholson HO. Cytotoxic drugs in pregnancy. J Obstet Gynaecol Br Commonw 1968;75:307.
9. Murray N, Acolet D, Deane M, Price J, Roberts I. Fetal marrow suppression after maternal chemotherapy for leukemia. Arch Dis Child 1994;71:F209-210.
10. Byrne J, Mulvihill JJ, Myers MH et al. Effects of treatment on fertility in long-term survivors of chilhood or adolescent cancer. N Engl J Med 1987;317:1315-121.
11. Feuilhade F, Calitchi E, Le Borgeois JP. Cancer du sein. Facteurs pronostiques et stratégie théapeutique. Cancer du sein et grossesse. Montpellier: Sauramps Medical, 1992:202-208.
12. Malone JM, Gershenson DM, Creasy RK, Kavanagh JJ, Silvia AG, Stringer A. Endodermal sinus tumor of the ovary associated with pregnancy. Obstet Gynecol 1986;68:86S-89S.
13. Giacalone PL, Laffargue F, Benos P, Rousseau O, Hedon B. Cisplatin neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma ot the uterine cervix. A case report. Br J Obstet Gynaecol 1996;103:932-934 .
14. Theriault R, Walters R, Holmes F, Buzdar A, hortobagyi G, Parisi V. Management of breast cancer during pregnancy. Proc Am Soc Clin Oncol 1992;86;A171.
15. Zemliskis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992;152:573-576.